Speranza Therapeutics announces value-based program for opioid detox facilities program vows to reduce costly facility against Medical Advice (AMA) leave rates
August 4, 2021
August 4, 2021
June 10, 2021
March 23, 2021
January 6, 2021
December 17, 2020
December 15, 2020
September 17, 2020
September 17, 2020
June 16, 2020
April 24, 2025
EpiCypher®, a leader in epigenomics innovation, announces the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation seq...
April 8, 2025
Enlarged Leadership Team with CSO, Prof. Dr. Anton Wellstein, and CBO, Dr. Matthias Evers Indivumed is proud to announce major milestones achieved, ce...
April 3, 2025
Innovative Knowledge Discovery Platform to Accelerate Research into Promising Therapeutic Targets for Parkinson’s Disease ONTOFORCE, a leader in seman...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225